CLEARMIND MEDICINE INC (CMND) Stock Overview
USA - NASDAQ:CMND - CA1850534027 - Common Stock
CMND Key Statistics, Chart & Performance
The current stock price of CMND is 1.01 USD. In the past month the price decreased by -3.81%. In the past year, price decreased by -30.82%.
CMND Latest News, Press Relases and Analysis
CMND Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 51.11 | 781.26B | ||
| JNJ | JOHNSON & JOHNSON | 18.34 | 458.55B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.76 | 258.24B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.73 | 252.36B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.65 | 235.32B | ||
| MRK | MERCK & CO. INC. | 11.36 | 218.53B | ||
| PFE | PFIZER INC | 7.3 | 140.77B | ||
| SNY | SANOFI-ADR | 11.74 | 125.85B | ||
| GSK | GSK PLC-SPON ADR | 9.65 | 86.97B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.51 | 89.21B | ||
| ZTS | ZOETIS INC | 23.46 | 64.68B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.04 | 44.25B |
Related stock screener links
About CMND
Company Profile
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Company Info
CLEARMIND MEDICINE INC
101-1220 West 6Th Avenue
Vancouver BRITISH COLUMBIA CA
Employees: 0
Phone: 16042601566
CLEARMIND MEDICINE INC / CMND FAQ
What does CMND do?
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Can you provide the latest stock price for CLEARMIND MEDICINE INC?
The current stock price of CMND is 1.01 USD. The price increased by 2.82% in the last trading session.
What is the dividend status of CLEARMIND MEDICINE INC?
CMND does not pay a dividend.
How is the ChartMill rating for CLEARMIND MEDICINE INC?
CMND has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the number of employees for CLEARMIND MEDICINE INC?
CLEARMIND MEDICINE INC (CMND) currently has 0 employees.
Can you provide the ownership details for CMND stock?
You can find the ownership structure of CLEARMIND MEDICINE INC (CMND) on the Ownership tab.
What is the Short Interest ratio of CLEARMIND MEDICINE INC (CMND) stock?
The outstanding short interest for CLEARMIND MEDICINE INC (CMND) is 1.37% of its float.
CMND Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CMND. When comparing the yearly performance of all stocks, CMND is a bad performer in the overall market: 85.81% of all stocks are doing better.
CMND Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CMND. The financial health of CMND is average, but there are quite some concerns on its profitability.
CMND Financial Highlights
Over the last trailing twelve months CMND reported a non-GAAP Earnings per Share(EPS) of -0.87. The EPS increased by 93.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -101.76% | ||
| ROE | -377.57% | ||
| Debt/Equity | 0 |